Suleman A, Tsui H, Ghorab Z, Lam PW, et al. EBV-positive diffuse large B-cell lymphoma following alemtuzumab therapy for T-cell prolymphocytic leukemia. Ann Hematol 2022 Nov 28. doi: 10.1007/s00277-022-05060.
PMID: 36441259